Capricor Therapeutics's total assets for Q2 2025 were $133.57M, a decrease of -13.13% from the previous quarter. CAPR total liabilities were $28.59M for the fiscal quarter, a 9.46% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.